Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.27 is 89% below its 5-year average of 2.52, near the low end of its 5-year range (0.27–8.15).
As of the fiscal period ended Tuesday, June 30, 2026. 67.34% below its 12-month average of 0.82.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.27.
QUICK RATIO (ACID-TEST)
0.27
QUICK RATIO (ACID-TEST) AVG TTM
0.82
QUICK RATIO (ACID-TEST) AVG 3Y
1.02
QUICK RATIO (ACID-TEST) AVG 5Y
2.52
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-67.34%
CURRENT VS 3Y AVG
-73.76%
CURRENT VS 5Y AVG
-89.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-92.01%
vs the sector median at left
Market Cap
$1.42M
Quick Ratio (Acid-Test)
0.67
TTM Avg
0.15
3Y Avg
0.14
5Y Avg
1.64
Market Cap
$1.47M
Quick Ratio (Acid-Test)
1.30
TTM Avg
2.54
3Y Avg
2.69
5Y Avg
2.23
Market Cap
$1.33M
Quick Ratio (Acid-Test)
0.62
TTM Avg
1.47
3Y Avg
0.74
5Y Avg
0.53
Market Cap
$1.49M
Quick Ratio (Acid-Test)
7.70
TTM Avg
0.13
3Y Avg
0.13
5Y Avg
0.13
Market Cap
$1.34M
Quick Ratio (Acid-Test)
3.00
TTM Avg
0.80
3Y Avg
7.12
5Y Avg
9.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NEXGEL, Inc. (NXGL) | $1.44M | 0.27 | 0.82 | 1.02 | 2.52 |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | 0.67 | 0.15 | 0.14 | 1.64 |
| Curis, Inc. (CRIS)vs › | $1.47M | 0.49 | 0.94 | 3.46 | 6.68 |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 1.30 | 2.54 | 2.69 | 2.23 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.33M | 0.62 | 1.47 | 0.74 | 0.53 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.49M | 7.70 | 0.13 | 0.13 | 0.13 |
| NewcelX Ltd. (NCEL)vs › | $1.37M | 0.32 | 1.73 | 1.61 | 1.48 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | 3.00 | 0.80 | 7.12 | 9.62 |
| Genprex, Inc. (GNPX)vs › | $1.36M | 6.77 | 2.33 | 3.65 | 16.80 |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | 5.36 | 7.82 | 13.02 | 13.86 |
Quick Ratio
0.27
Excludes inventory
Current Ratio
0.43
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.27 |
| 2026-03-31 | 1.02 |
| 2025-12-31 | 0.75 |
| 2025-09-30 | 1.08 |
| 2025-06-30 | 0.98 |
| 2025-03-31 | 1.15 |
| 2024-12-31 | 1.36 |
| 2024-09-30 | 0.93 |
| 2024-06-30 | 0.81 |
| 2024-03-31 | 1.41 |
| 2023-12-31 | 1.46 |
| 2023-09-30 | 2.92 |
| 2023-06-30 | 3.36 |
| 2023-03-31 | 4.15 |
| 2022-12-31 | 8.15 |
| 2022-09-30 | 7.10 |
| 2022-06-30 | 4.18 |
| 2022-03-31 | 6.00 |
| 2021-12-31 | 4.72 |
| 2021-09-30 | 0.64 |
| 2021-06-30 | 0.39 |
| 2021-03-31 | 0.75 |
| 2020-12-31 | 0.10 |
| 2020-09-30 | 0.32 |
| 2020-06-30 | 0.38 |
| 2020-03-31 | 0.68 |
| 2019-12-31 | 0.50 |
| 2019-09-30 | 0.35 |
| 2019-06-30 | 0.33 |
| 2019-03-31 | 0.50 |
| 2018-12-31 | 0.64 |
| 2018-09-30 | 0.91 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.50 |
